A Aralex Aachen research explorer

June 05, 2020 article Open access

Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interventional study

Journal of Antimicrobial Chemotherapy

DOI: 10.1093/jac/dkaa267 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 4 stored of 39

Relationship between continuous infusion meropenem PK/PD target attainment and C‐reactive protein dynamics in onco‐haematologic patients with febrile neutropenia
2026 British Journal of Clinical Pharmacology article Medicine Neutropenia and Cancer Infections Open access

0

citations
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia
2024 Clinical Pharmacokinetics article Medicine Antibiotics Pharmacokinetics and Efficacy Open access

3

citations
A Systematic Review of the Effect of Therapeutic Drug Monitoring on Patient Health Outcomes during Treatment with Carbapenems
2022 Antibiotics review Medicine Antibiotics Pharmacokinetics and Efficacy Open access

14

citations
Comparison of two empirical prolonged infusion dosing regimens for meropenem in patients with septic shock: A two-center pilot study
2021 International Journal of Antimicrobial Agents article Medicine Antibiotics Pharmacokinetics and Efficacy Open access

14

citations

4 results

References 0